{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:25:20Z","timestamp":1790036720754,"version":"4.0.1"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Liaoning Provincial Science and Technology Plan Joint Program","award":["No. 2025-MSLH-763"],"award-info":[{"award-number":["No. 2025-MSLH-763"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04652-3","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T03:55:26Z","timestamp":1780977326000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ferroptosis-driven immune remodeling in heart failure: the central role of macrophage reprogramming and impaired efferocytosis"],"prefix":"10.1186","volume":"24","author":[{"given":"Haoyuan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxiao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"4652_CR1","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","volume":"118","author":"G Savarese","year":"2022","unstructured":"Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovascular Res. 2022;118:3272\u201387. https:\/\/doi.org\/10.1093\/cvr\/cvac013.","journal-title":"Cardiovascular Res"},{"key":"4652_CR2","doi-asserted-by":"publisher","unstructured":"Shahim B, Kapelios CJ, Savarese G, Lund LH. Global Public Health Burden of Heart Failure: An Updated Review. Cardiac Fail Rev. 2023;9. https:\/\/doi.org\/10.15420\/cfr.2023.05.","DOI":"10.15420\/cfr.2023.05"},{"key":"4652_CR3","doi-asserted-by":"publisher","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145. https:\/\/doi.org\/10.1161\/cir.0000000000001063.","DOI":"10.1161\/cir.0000000000001063"},{"key":"4652_CR4","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1056\/nejmoa2206286","volume":"387","author":"SD Solomon","year":"2022","unstructured":"Solomon SD, McMurray JJV, Claggett B, de Boer RA, DeMets D, Hernandez AF, et al. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. N Engl J Med. 2022;387:1089\u201398. https:\/\/doi.org\/10.1056\/nejmoa2206286.","journal-title":"N Engl J Med"},{"key":"4652_CR5","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1093\/eurheartj\/ehab364","volume":"42","author":"M Glikson","year":"2021","unstructured":"Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021;42:3427\u2013520. https:\/\/doi.org\/10.1093\/eurheartj\/ehab364.","journal-title":"Eur Heart J"},{"key":"4652_CR6","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41586-024-08008-5","volume":"635","author":"JM Amrute","year":"2024","unstructured":"Amrute JM, Luo X, Penna V, Yang S, Yamawaki T, Hayat S, et al. Targeting immune\u2013fibroblast cell communication in heart failure. Nature. 2024;635:423\u201333. https:\/\/doi.org\/10.1038\/s41586-024-08008-5.","journal-title":"Nature"},{"key":"4652_CR7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.tem.2023.10.010","volume":"35","author":"Q Xiang","year":"2024","unstructured":"Xiang Q, Yi X, Zhu X-H, Wei X, Jiang D-S. Regulated cell death in myocardial ischemia\u2013reperfusion injury. Trends Endocrinol Metabolism. 2024;35:219\u201334. https:\/\/doi.org\/10.1016\/j.tem.2023.10.010.","journal-title":"Trends Endocrinol Metabolism"},{"key":"4652_CR8","doi-asserted-by":"publisher","first-page":"103211","DOI":"10.1016\/j.redox.2024.103211","volume":"75","author":"C Berndt","year":"2024","unstructured":"Berndt C, Alborzinia H, Amen VS, Ayton S, Barayeu U, Bartelt A, et al. Ferroptosis in health and disease. Redox Biol. 2024;75:103211. https:\/\/doi.org\/10.1016\/j.redox.2024.103211.","journal-title":"Redox Biol"},{"key":"4652_CR9","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1161\/circulationaha.122.060257","volume":"147","author":"W Cai","year":"2023","unstructured":"Cai W, Liu L, Shi X, Liu Y, Wang J, Fang X, et al. Alox15\/15-HpETE Aggravates Myocardial Ischemia-Reperfusion Injury by Promoting Cardiomyocyte Ferroptosis. Circulation. 2023;147:1444\u201360. https:\/\/doi.org\/10.1161\/circulationaha.122.060257.","journal-title":"Circulation"},{"key":"4652_CR10","doi-asserted-by":"publisher","first-page":"102825","DOI":"10.1016\/j.redox.2023.102825","volume":"65","author":"B Wang","year":"2023","unstructured":"Wang B, Jin Y, Liu J, Liu Q, Shen Y, Zuo S, et al. EP1 activation inhibits doxorubicin-cardiomyocyte ferroptosis via Nrf2. Redox Biol. 2023;65:102825. https:\/\/doi.org\/10.1016\/j.redox.2023.102825.","journal-title":"Redox Biol"},{"key":"4652_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.yjmcc.2022.10.004","volume":"173","author":"X Yang","year":"2022","unstructured":"Yang X, Kawasaki NK, Min J, Matsui T, Wang F. Ferroptosis in heart failure. J Mol Cell Cardiol. 2022;173:141\u201353. https:\/\/doi.org\/10.1016\/j.yjmcc.2022.10.004.","journal-title":"J Mol Cell Cardiol"},{"key":"4652_CR12","doi-asserted-by":"publisher","unstructured":"Zuo W, Sun R, Ji Z, Ma G. Macrophage-driven cardiac inflammation and healing: insights from homeostasis and myocardial infarction. Cellular & Molecular Biology Letters. 2023;28. https:\/\/doi.org\/10.1186\/s11658-023-00491-4.","DOI":"10.1186\/s11658-023-00491-4."},{"key":"4652_CR13","doi-asserted-by":"publisher","unstructured":"Wang X, Du W, Li Y, Yang H-H, Zhang Y, Akbar R, et al. Macrophage-enriched Sectm1a promotes efficient efferocytosis to attenuate ischemia\/reperfusion-induced cardiac injury. JCI Insight. 2024;9. https:\/\/doi.org\/10.1172\/jci.insight.173832.","DOI":"10.1172\/jci.insight.173832"},{"key":"4652_CR14","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/s41418-024-01351-0","volume":"31","author":"X Luo","year":"2024","unstructured":"Luo X, Gong H-B, Li Z-C, Li D-D, Li Z-X, Sun J, et al. Phospholipid peroxidation in macrophage confers tumor resistance by suppressing phagocytic capability towards ferroptotic cells. Cell Death Differ. 2024;31:1184\u2013201. https:\/\/doi.org\/10.1038\/s41418-024-01351-0.","journal-title":"Cell Death Differ"},{"key":"4652_CR15","doi-asserted-by":"publisher","unstructured":"Yang F, Xue J, Wang G, Diao Q. Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases. Front Pharmacol. 2022;13. https:\/\/doi.org\/10.3389\/fphar.2022.999404.","DOI":"10.3389\/fphar.2022.999404"},{"key":"4652_CR16","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1161\/circresaha.124.324608","volume":"135","author":"L Tang","year":"2024","unstructured":"Tang L, Qiu H, Xu B, Su Y, Nyarige V, Li P, et al. Microparticle Mediated Delivery of Apelin Improves Heart Function in Post Myocardial Infarction Mice. Circul Res. 2024;135:777\u201398. https:\/\/doi.org\/10.1161\/circresaha.124.324608.","journal-title":"Circul Res"},{"key":"4652_CR17","doi-asserted-by":"publisher","unstructured":"Ru Q, Li Y, Chen L, Wu Y, Min J, Wang F. Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects. Signal Transduct Target Therapy. 2024;9. https:\/\/doi.org\/10.1038\/s41392-024-01969-z.","DOI":"10.1038\/s41392-024-01969-z"},{"key":"4652_CR18","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3390\/ijms24010449","volume":"24","author":"L Rochette","year":"2022","unstructured":"Rochette L, Dogon G, Rigal E, Zeller M, Cottin Y, Vergely C. Lipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis. Int J Mol Sci. 2022;24:449. https:\/\/doi.org\/10.3390\/ijms24010449.","journal-title":"Int J Mol Sci"},{"key":"4652_CR19","doi-asserted-by":"publisher","first-page":"7038","DOI":"10.1111\/febs.16059","volume":"289","author":"J Liu","year":"2021","unstructured":"Liu J, Kang R, Tang D. Signaling pathways and defense mechanisms of ferroptosis. FEBS J. 2021;289:7038\u201350. https:\/\/doi.org\/10.1111\/febs.16059.","journal-title":"FEBS J"},{"key":"4652_CR20","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3390\/cells12050804","volume":"12","author":"MS Mortensen","year":"2023","unstructured":"Mortensen MS, Ruiz J, Watts JL. Polyunsaturated Fatty Acids Drive Lipid Peroxidation during Ferroptosis. Cells. 2023;12:804. https:\/\/doi.org\/10.3390\/cells12050804.","journal-title":"Cells"},{"key":"4652_CR21","doi-asserted-by":"publisher","unstructured":"Zhang K, Tian X-M, Li W, Hao L-Y. Ferroptosis in cardiac hypertrophy and heart failure. Biomedicine & Pharmacotherapy. 2023;168:115765. https:\/\/doi.org\/10.1016\/j.biopha.2023.115765.","DOI":"10.1016\/j.biopha.2023.115765."},{"key":"4652_CR22","doi-asserted-by":"publisher","unstructured":"Yan J, Li Z, Liang Y, Yang C, Ou W, Mo H, et al. Fucoxanthin alleviated myocardial ischemia and reperfusion injury through inhibition of ferroptosis via the NRF2 signaling pathway. Food & Function. 2023;14:10052\u201368. https:\/\/doi.org\/10.1039\/d3fo02633g.","DOI":"10.1039\/d3fo02633g."},{"key":"4652_CR23","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1161\/circresaha.123.323882","volume":"134","author":"A Mendoza","year":"2024","unstructured":"Mendoza A, Patel P, Robichaux D, Ramirez D, Karch J. Inhibition of the mPTP and Lipid Peroxidation Is Additively Protective Against I\/R Injury. Circul Res. 2024;134:1292\u2013305. https:\/\/doi.org\/10.1161\/circresaha.123.323882.","journal-title":"Circul Res"},{"key":"4652_CR24","doi-asserted-by":"publisher","first-page":"9367","DOI":"10.1080\/21655979.2021.2001913","volume":"12","author":"Z Xiao","year":"2021","unstructured":"Xiao Z, Kong B, Fang J, Qin T, Dai C, Shuai W, et al. Ferrostatin-1 alleviates lipopolysaccharide-induced cardiac dysfunction. Bioengineered. 2021;12:9367\u201376. https:\/\/doi.org\/10.1080\/21655979.2021.2001913.","journal-title":"Bioengineered"},{"key":"4652_CR25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/nu15030591","volume":"15","author":"Y Chen","year":"2023","unstructured":"Chen Y, Li X, Wang S, Miao R, Zhong J. Targeting Iron Metabolism and Ferroptosis as Novel Therapeutic Approaches in Cardiovascular Diseases. Nutrients. 2023;15:591. https:\/\/doi.org\/10.3390\/nu15030591.","journal-title":"Nutrients"},{"key":"4652_CR26","doi-asserted-by":"publisher","unstructured":"Bi X, Wu X, Chen J, Li X, Lin Y, Yu Y, et al. Characterization of ferroptosis-triggered pyroptotic signaling in heart failure. Signal Transduct Target Therapy. 2024;9. https:\/\/doi.org\/10.1038\/s41392-024-01962-6.","DOI":"10.1038\/s41392-024-01962-6"},{"key":"4652_CR27","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1161\/circresaha.122.321667","volume":"132","author":"KT Sawicki","year":"2023","unstructured":"Sawicki KT, De Jesus A, Ardehali H. Iron Metabolism in Cardiovascular Disease: Physiology, Mechanisms, and Therapeutic Targets. Circul Res. 2023;132:379\u201396. https:\/\/doi.org\/10.1161\/circresaha.122.321667.","journal-title":"Circul Res"},{"key":"4652_CR28","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1161\/circresaha.123.324103","volume":"135","author":"A Yoshii","year":"2024","unstructured":"Yoshii A, McMillen TS, Wang Y, Zhou B, Chen H, Banerjee D, et al. Blunted Cardiac Mitophagy in Response to Metabolic Stress Contributes to HFpEF. Circul Res. 2024;135:1004\u201317. https:\/\/doi.org\/10.1161\/circresaha.123.324103.","journal-title":"Circul Res"},{"key":"4652_CR29","doi-asserted-by":"publisher","unstructured":"Tian M, Huang X, Li M, Lou P, Ma H, Jiang X, et al. Ferroptosis in diabetic cardiomyopathy: from its mechanisms to therapeutic strategies. Front Endocrinol. 2024;15. https:\/\/doi.org\/10.3389\/fendo.2024.1421838.","DOI":"10.3389\/fendo.2024.1421838"},{"key":"4652_CR30","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1093\/eurheartj\/ehae086","volume":"45","author":"JGF Cleland","year":"2024","unstructured":"Cleland JGF, Kalra PA, Pellicori P, Graham FJ, Foley PWX, Squire IB, et al. Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial. Eur Heart J. 2024;45:1410\u201326. https:\/\/doi.org\/10.1093\/eurheartj\/ehae086.","journal-title":"Eur Heart J"},{"key":"4652_CR31","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/ejhf.2810","volume":"25","author":"FJ Graham","year":"2023","unstructured":"Graham FJ, Pellicori P, Kalra PR, Ford I, Bruzzese D, Cleland JGF. Intravenous Iron in Patients with Heart Failure and Iron Deficiency: An Updated Meta-Analysis. Eur J Heart Fail. 2023;25:528\u201337. https:\/\/doi.org\/10.1002\/ejhf.2810.","journal-title":"Eur J Heart Fail"},{"key":"4652_CR32","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/ejhf.3237","volume":"26","author":"M Packer","year":"2024","unstructured":"Packer M, Anker SD, Butler J, Cleland JGF, Kalra PR, Mentz RJ, et al. Critical Re-Evaluation of the Identification of Iron Deficiency States and Effective Iron Repletion Strategies in Patients with Chronic Heart Failure. Eur J Heart Fail. 2024;26:1298\u2013312. https:\/\/doi.org\/10.1002\/ejhf.3237.","journal-title":"Eur J Heart Fail"},{"key":"4652_CR33","doi-asserted-by":"publisher","first-page":"111872","DOI":"10.1016\/j.biopha.2021.111872","volume":"141","author":"Y Qin","year":"2021","unstructured":"Qin Y, Qiao Y, Wang D, Tang C, Yan G. Ferritinophagy and ferroptosis in cardiovascular disease: Mechanisms and potential applications. Biomed Pharmacother. 2021;141:111872. https:\/\/doi.org\/10.1016\/j.biopha.2021.111872.","journal-title":"Biomed Pharmacother"},{"key":"4652_CR34","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.tcb.2023.05.003","volume":"33","author":"LE Pope","year":"2023","unstructured":"Pope LE, Dixon SJ. Regulation of ferroptosis by lipid metabolism. Trends Cell Biol. 2023;33:1077\u201387. https:\/\/doi.org\/10.1016\/j.tcb.2023.05.003.","journal-title":"Trends Cell Biol"},{"key":"4652_CR35","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1080\/15548627.2023.2165323","volume":"19","author":"Q Xue","year":"2023","unstructured":"Xue Q, Yan D, Chen X, Li X, Kang R, Klionsky DJ, et al. Copper-dependent autophagic degradation of GPX4 drives ferroptosis. Autophagy. 2023;19:1982\u201396. https:\/\/doi.org\/10.1080\/15548627.2023.2165323.","journal-title":"Autophagy"},{"key":"4652_CR36","doi-asserted-by":"publisher","first-page":"103259","DOI":"10.1016\/j.redox.2024.103259","volume":"75","author":"Y Wang","year":"2024","unstructured":"Wang Y, Yan D, Liu J, Tang D, Chen X. Protein modification and degradation in ferroptosis. Redox Biol. 2024;75:103259. https:\/\/doi.org\/10.1016\/j.redox.2024.103259.","journal-title":"Redox Biol"},{"key":"4652_CR37","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.1002\/ehf2.15406","volume":"12","author":"E Fiori","year":"2025","unstructured":"Fiori E, Davinelli S, Ferrera A, Medoro A, Barsali C, Battistoni A, et al. The Emerging Role of Nrf2 in Heart Failure: From Cardioprotection to Therapeutic Approaches. ESC Heart Fail. 2025;12:4000\u201320. https:\/\/doi.org\/10.1002\/ehf2.15406.","journal-title":"ESC Heart Fail"},{"key":"4652_CR38","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.tips.2023.08.012","volume":"44","author":"C Scarpellini","year":"2023","unstructured":"Scarpellini C, Klejborowska G, Lanthier C, Hassannia B, Vanden Berghe T, Augustyns K. Beyond ferrostatin-1: a comprehensive review of ferroptosis inhibitors. Trends Pharmacol Sci. 2023;44:902\u201316. https:\/\/doi.org\/10.1016\/j.tips.2023.08.012.","journal-title":"Trends Pharmacol Sci"},{"key":"4652_CR39","doi-asserted-by":"publisher","first-page":"102164","DOI":"10.1016\/j.redox.2021.102164","volume":"47","author":"AD Read","year":"2021","unstructured":"Read AD, Bentley RET, Archer SL, Dunham-Snary KJ. Mitochondrial iron\u2013sulfur clusters: Structure, function, and an emerging role in vascular biology. Redox Biol. 2021;47:102164. https:\/\/doi.org\/10.1016\/j.redox.2021.102164.","journal-title":"Redox Biol"},{"key":"4652_CR40","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1161\/circresaha.124.323800","volume":"135","author":"A Hinton Jr","year":"2024","unstructured":"Hinton A Jr, Claypool SM, Neikirk K, Senoo N, Wanjalla CN, Kirabo A, et al. Mitochondrial Structure and Function in Human Heart Failure. Circul Res. 2024;135:372\u201396. https:\/\/doi.org\/10.1161\/circresaha.124.323800.","journal-title":"Circul Res"},{"key":"4652_CR41","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.cmet.2022.08.017","volume":"34","author":"S Ahola","year":"2022","unstructured":"Ahola S, Rivera Mej\u00edas P, Hermans S, Chandragiri S, Giavalisco P, Nolte H, et al. OMA1-mediated integrated stress response protects against ferroptosis in mitochondrial cardiomyopathy. Cell Metabol. 2022;34:1875\u2013e18917. https:\/\/doi.org\/10.1016\/j.cmet.2022.08.017.","journal-title":"Cell Metabol"},{"key":"4652_CR42","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.freeradbiomed.2023.06.019","volume":"206","author":"T Ye","year":"2023","unstructured":"Ye T, Yang W, Gao T, Yu X, Chen T, Yang Y, et al. Trastuzumab-induced cardiomyopathy via ferroptosis-mediated mitochondrial dysfunction. Free Radic Biol Med. 2023;206:143\u201361. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.06.019.","journal-title":"Free Radic Biol Med"},{"key":"4652_CR43","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1016\/j.molcel.2024.07.020","volume":"84","author":"FG Liang","year":"2024","unstructured":"Liang FG, Zandkarimi F, Lee J, Axelrod JL, Pekson R, Yoon Y, et al. OPA1 promotes ferroptosis by augmenting mitochondrial ROS and suppressing an integrated stress response. Mol Cell. 2024;84:3098\u2013e31146. https:\/\/doi.org\/10.1016\/j.molcel.2024.07.020.","journal-title":"Mol Cell"},{"key":"4652_CR44","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.7150\/ijbs.83348","volume":"19","author":"J Li","year":"2023","unstructured":"Li J, Jia Y, Ding Y, Bai J, Cao F, Li F. The crosstalk between ferroptosis and mitochondrial dynamic regulatory networks. Int J Biol Sci. 2023;19:2756\u201371. https:\/\/doi.org\/10.7150\/ijbs.83348.","journal-title":"Int J Biol Sci"},{"key":"4652_CR45","doi-asserted-by":"publisher","unstructured":"Li K, Samiei S, Pikulska D, Foecking S, Kuppe C. Advancing Cardiovascular Research With Single-Cell and Spatial Transcriptomics. Circul Res. 2026;138. https:\/\/doi.org\/10.1161\/circresaha.125.325795.","DOI":"10.1161\/circresaha.125.325795"},{"key":"4652_CR46","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.immuni.2022.08.009","volume":"55","author":"R Zaman","year":"2022","unstructured":"Zaman R, Epelman S. Resident cardiac macrophages: Heterogeneity and function in health and disease. Immunity. 2022;55:1549\u201363. https:\/\/doi.org\/10.1016\/j.immuni.2022.08.009.","journal-title":"Immunity"},{"key":"4652_CR47","doi-asserted-by":"publisher","first-page":"103992","DOI":"10.1016\/j.ebiom.2022.103992","volume":"79","author":"GV Halade","year":"2022","unstructured":"Halade GV, Lee DH. Inflammation and resolution signaling in cardiac repair and heart failure. eBioMedicine. 2022;79:103992. https:\/\/doi.org\/10.1016\/j.ebiom.2022.103992.","journal-title":"eBioMedicine"},{"key":"4652_CR48","doi-asserted-by":"publisher","unstructured":"Yin W, Chen Y, Wang W, Guo M, Tong L, Zhang M, et al. Macrophage-mediated heart repair and remodeling: A promising therapeutic target for post\u2010myocardial infarction heart failure. J Cell Physiol. 2024;239. https:\/\/doi.org\/10.1002\/jcp.31372.","DOI":"10.1002\/jcp.31372"},{"key":"4652_CR49","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1161\/circulationaha.122.062984","volume":"150","author":"C Panico","year":"2024","unstructured":"Panico C, Felicetta A, Kunderfranco P, Cremonesi M, Salvarani N, Carullo P, et al. Single-Cell RNA Sequencing Reveals Metabolic Stress-Dependent Activation of Cardiac Macrophages in a Model of Dyslipidemia-Induced Diastolic Dysfunction. Circulation. 2024;150:1517\u201332. https:\/\/doi.org\/10.1161\/circulationaha.122.062984.","journal-title":"Circulation"},{"key":"4652_CR50","doi-asserted-by":"publisher","unstructured":"Hou P, Fang J, Liu Z, Shi Y, Agostini M, Bernassola F, et al. Macrophage polarization and metabolism in atherosclerosis. Cell Death & Disease. 2023;14. https:\/\/doi.org\/10.1038\/s41419-023-06206-z.","DOI":"10.1038\/s41419-023-06206-z."},{"key":"4652_CR51","doi-asserted-by":"publisher","unstructured":"Ordaz-Arias MA, D\u00edaz-Alvarez L, Z\u00fa\u00f1iga J, Martinez-S\u00e1nchez ME, Balderas-Mart\u00ednez YI. Cyclic Attractors Are Critical for Macrophage Differentiation, Heterogeneity, and Plasticity. Front Mol Biosci. 2022;9. https:\/\/doi.org\/10.3389\/fmolb.2022.807228.","DOI":"10.3389\/fmolb.2022.807228"},{"key":"4652_CR52","doi-asserted-by":"publisher","unstructured":"Bao Q, Zhang B, Zhou L, Yang Q, Mu X, Liu X, et al. CNP Ameliorates Macrophage Inflammatory Response and Atherosclerosis. Circul Res. 2024;134. https:\/\/doi.org\/10.1161\/circresaha.123.324086.","DOI":"10.1161\/circresaha.123.324086"},{"key":"4652_CR53","doi-asserted-by":"publisher","unstructured":"Wculek SK, Dunphy G, Heras-Murillo I, Mastrangelo A, Sancho D. Metabolism of tissue macrophages in homeostasis and pathology. Cellular & Molecular Immunology. 2021;19:384\u2013408. https:\/\/doi.org\/10.1038\/s41423-021-00791-9.","DOI":"10.1038\/s41423-021-00791-9."},{"key":"4652_CR54","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s42255-023-00736-8","volume":"5","author":"M Schilperoort","year":"2023","unstructured":"Schilperoort M, Ngai D, Katerelos M, Power DA, Tabas I. PFKFB2-mediated glycolysis promotes lactate-driven continual efferocytosis by macrophages. Nat Metabolism. 2023;5:431\u201344. https:\/\/doi.org\/10.1038\/s42255-023-00736-8.","journal-title":"Nat Metabolism"},{"key":"4652_CR55","doi-asserted-by":"publisher","unstructured":"Thorp EB. Cardiac macrophages and emerging roles for their metabolism after myocardial infarction. J Clin Invest. 2023;133. https:\/\/doi.org\/10.1172\/jci171953.","DOI":"10.1172\/jci171953"},{"key":"4652_CR56","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1161\/circulationaha.123.065506","volume":"149","author":"S Zhang","year":"2024","unstructured":"Zhang S, Zhang Y, Duan X, Wang B, Zhan Z. Targeting NPM1 Epigenetically Promotes Postinfarction Cardiac Repair by Reprogramming Reparative Macrophage Metabolism. Circulation. 2024;149:1982\u20132001. https:\/\/doi.org\/10.1161\/circulationaha.123.065506.","journal-title":"Circulation"},{"key":"4652_CR57","doi-asserted-by":"publisher","unstructured":"Kopecky BJ, Lavine KJ. Cardiac macrophage metabolism in health and disease. Trends in Endocrinology & Metabolism. 2024;35:249\u201362. https:\/\/doi.org\/10.1016\/j.tem.2023.10.011.","DOI":"10.1016\/j.tem.2023.10.011."},{"key":"4652_CR58","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3390\/biom14111403","volume":"14","author":"S Psarras","year":"2024","unstructured":"Psarras S. The Macrophage\u2013Fibroblast Dipole in the Context of Cardiac Repair and Fibrosis. Biomolecules. 2024;14:1403. https:\/\/doi.org\/10.3390\/biom14111403.","journal-title":"Biomolecules"},{"key":"4652_CR59","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-024-08085-6","volume":"635","author":"M Alexanian","year":"2024","unstructured":"Alexanian M, Padmanabhan A, Nishino T, Travers JG, Ye L, Pelonero A, et al. Chromatin remodelling drives immune cell\u2013fibroblast communication in heart failure. Nature. 2024;635:434\u201343. https:\/\/doi.org\/10.1038\/s41586-024-08085-6.","journal-title":"Nature"},{"key":"4652_CR60","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/shk.0000000000001625","volume":"55","author":"Y Li","year":"2020","unstructured":"Li Y, Li Q, Fan G-C. Macrophage Efferocytosis in Cardiac Pathophysiology and Repair. Shock. 2020;55:177\u201388. https:\/\/doi.org\/10.1097\/shk.0000000000001625.","journal-title":"Shock"},{"key":"4652_CR61","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1161\/circresaha.121.319737","volume":"129","author":"XS Revelo","year":"2021","unstructured":"Revelo XS, Parthiban P, Chen C, Barrow F, Fredrickson G, Wang H, et al. Cardiac Resident Macrophages Prevent Fibrosis and Stimulate Angiogenesis. Circul Res. 2021;129:1086\u2013101. https:\/\/doi.org\/10.1161\/circresaha.121.319737.","journal-title":"Circul Res"},{"key":"4652_CR62","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.immuni.2024.03.019","volume":"57","author":"HN Bell","year":"2024","unstructured":"Bell HN, Stockwell BR, Zou W. Ironing out the role of ferroptosis in immunity. Immunity. 2024;57:941\u201356. https:\/\/doi.org\/10.1016\/j.immuni.2024.03.019.","journal-title":"Immunity"},{"key":"4652_CR63","doi-asserted-by":"publisher","unstructured":"Yang Y, Wang Y, Guo L, Gao W, Tang T-L, Yan M. Interaction between macrophages and ferroptosis. Cell Death Dis. 2022;13. https:\/\/doi.org\/10.1038\/s41419-022-04775-z.","DOI":"10.1038\/s41419-022-04775-z"},{"key":"4652_CR64","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/imr.13235","volume":"321","author":"D Tang","year":"2023","unstructured":"Tang D, Kroemer G, Kang R. Ferroptosis in immunostimulation and immunosuppression. Immunol Rev. 2023;321:199\u2013210. https:\/\/doi.org\/10.1111\/imr.13235.","journal-title":"Immunol Rev"},{"key":"4652_CR65","doi-asserted-by":"publisher","unstructured":"Luo X, Gong H-B, Gao H-Y, Wu Y-P, Sun W-Y, Li Z-Q, et al. Oxygenated phosphatidylethanolamine navigates phagocytosis of ferroptotic cells by interacting with TLR2. Cell Death & Differentiation. 2021;28:1971\u201389. https:\/\/doi.org\/10.1038\/s41418-020-00719-2.","DOI":"10.1038\/s41418-020-00719-2."},{"key":"4652_CR66","doi-asserted-by":"publisher","unstructured":"Yang Y-C, Jiang Q, Yang K-P, Wang L, Sethi G, Ma Z. Extracellular vesicle-mediated ferroptosis, pyroptosis, and necroptosis: potential clinical applications in cancer therapy. Cell Death Discovery. 2024;10. https:\/\/doi.org\/10.1038\/s41420-024-01799-6.","DOI":"10.1038\/s41420-024-01799-6"},{"key":"4652_CR67","doi-asserted-by":"publisher","unstructured":"Chen Y, Fang Z-M, Yi X, Wei X, Jiang D-S. The interaction between ferroptosis and inflammatory signaling pathways. Cell Death Dis. 2023;14. https:\/\/doi.org\/10.1038\/s41419-023-05716-0.","DOI":"10.1038\/s41419-023-05716-0"},{"key":"4652_CR68","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jare.2024.12.019","volume":"76","author":"Y-X Hu","year":"2025","unstructured":"Hu Y-X, You H-M, Bai M-R, Yue W-H, Li F-F, Hu B-W, et al. Macrophage P2Y12 regulates iron transport and its inhibition protects against atherosclerosis. J Adv Res. 2025;76:585\u2013603. https:\/\/doi.org\/10.1016\/j.jare.2024.12.019.","journal-title":"J Adv Res"},{"key":"4652_CR69","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/intimm\/dxx031","volume":"29","author":"KF Kernan","year":"2017","unstructured":"Kernan KF, Carcillo JA. Hyperferritinemia and inflammation. Int Immunol. 2017;29:401\u20139. https:\/\/doi.org\/10.1093\/intimm\/dxx031.","journal-title":"Int Immunol"},{"key":"4652_CR70","doi-asserted-by":"publisher","unstructured":"Xing Y, Wang M, Zhang F, Xin T, Wang X, Chen R, et al. Lysosomes finely control macrophage inflammatory function via regulating the release of lysosomal Fe2 + through TRPML1 channel. Nat Commun. 2025;16. https:\/\/doi.org\/10.1038\/s41467-025-56403-x.","DOI":"10.1038\/s41467-025-56403-x"},{"key":"4652_CR71","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/s42255-024-01053-4","volume":"6","author":"H Sekine","year":"2024","unstructured":"Sekine H, Takeda H, Takeda N, Kishino A, Anzawa H, Isagawa T, et al. PNPO\u2013PLP axis senses prolonged hypoxia in macrophages by regulating lysosomal activity. Nat Metabolism. 2024;6:1108\u201327. https:\/\/doi.org\/10.1038\/s42255-024-01053-4.","journal-title":"Nat Metabolism"},{"key":"4652_CR72","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/cm9.0000000000003189","volume":"138","author":"Q Jiang","year":"2024","unstructured":"Jiang Q, Wan R, Jiang J, Li T, Li Y, Yu S, et al. Interaction between macrophages and ferroptosis: Metabolism, function, and diseases. Chin Med J. 2024;138:509\u201322. https:\/\/doi.org\/10.1097\/cm9.0000000000003189.","journal-title":"Chin Med J"},{"key":"4652_CR73","doi-asserted-by":"publisher","unstructured":"Guo D, Yang X, Yu R, Geng J, Zhang X, Wang Y, et al. Macrophage-derived extracellular vesicles represent a promising endogenous iron-chelating therapy for iron overload and cardiac injury in myocardial infarction. J Nanobiotechnol. 2024;22. https:\/\/doi.org\/10.1186\/s12951-024-02800-1.","DOI":"10.1186\/s12951-024-02800-1"},{"key":"4652_CR74","doi-asserted-by":"publisher","first-page":"E376","DOI":"10.1152\/ajpendo.00116.2021","volume":"321","author":"NC Winn","year":"2021","unstructured":"Winn NC, Wolf EM, Cottam MA, Bhanot M, Hasty AH. Myeloid-specific deletion of ferroportin impairs macrophage bioenergetics but is disconnected from systemic insulin action in adult mice. Am J Physiology-Endocrinology Metabolism. 2021;321:E376\u201391. https:\/\/doi.org\/10.1152\/ajpendo.00116.2021.","journal-title":"Am J Physiology-Endocrinology Metabolism"},{"key":"4652_CR75","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1146\/annurev-pathmechdis-111523-023405","volume":"20","author":"EB Thorp","year":"2025","unstructured":"Thorp EB, Filipp M. Contributions of Inflammation to Cardiometabolic Heart Failure with Preserved Ejection Fraction. Annu Rev Pathol. 2025;20:143\u201367. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-111523-023405.","journal-title":"Annu Rev Pathol"},{"key":"4652_CR76","doi-asserted-by":"publisher","first-page":"Supplement1","DOI":"10.1093\/eurheartj\/ehab724.3298","volume":"42","author":"J Kneuer","year":"2021","unstructured":"Kneuer J, Meinecke T, Weiss R, Gaul S, Haas J, Meder B, et al. The long non-coding RNA Heat4 is upregulated in heart failure and decreases the immune response of non-classical monocytes. Eur Heart J. 2021;42:Supplement1. https:\/\/doi.org\/10.1093\/eurheartj\/ehab724.3298.","journal-title":"Eur Heart J"},{"key":"4652_CR77","doi-asserted-by":"publisher","unstructured":"Gonzalez AL, Dungan MM, Smart CD, Madhur MS, Doran AC. Inflammation Resolution in the Cardiovascular System: Arterial Hypertension, Atherosclerosis, and Ischemic Heart Disease. Antioxidants & Redox Signaling. 2024;40:292\u2013316. https:\/\/doi.org\/10.1089\/ars.2023.0284.","DOI":"10.1089\/ars.2023.0284."},{"key":"4652_CR78","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1161\/circresaha.124.323659","volume":"134","author":"P Alcaide","year":"2024","unstructured":"Alcaide P, Kallikourdis M, Emig R, Prabhu SD. Myocardial Inflammation in Heart Failure With Reduced and Preserved Ejection Fraction. Circul Res. 2024;134:1752\u201366. https:\/\/doi.org\/10.1161\/circresaha.124.323659.","journal-title":"Circul Res"},{"key":"4652_CR79","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/imr.13214","volume":"319","author":"M Schilperoort","year":"2023","unstructured":"Schilperoort M, Ngai D, Sukka SR, Avrampou K, Shi H, Tabas I. The role of efferocytosis-fueled macrophage metabolism in the resolution of inflammation. Immunol Rev. 2023;319:65\u201380. https:\/\/doi.org\/10.1111\/imr.13214.","journal-title":"Immunol Rev"},{"key":"4652_CR80","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41573-022-00470-y","volume":"21","author":"P Mehrotra","year":"2022","unstructured":"Mehrotra P, Ravichandran KS. Drugging the efferocytosis process: concepts and opportunities. Nat Rev Drug Discovery. 2022;21:601\u201320. https:\/\/doi.org\/10.1038\/s41573-022-00470-y.","journal-title":"Nat Rev Drug Discovery"},{"key":"4652_CR81","doi-asserted-by":"publisher","unstructured":"Moon B, Yang S, Moon H, Lee J, Park D. After cell death: the molecular machinery of efferocytosis. Experimental & Molecular Medicine. 2023;55:1644\u201351. https:\/\/doi.org\/10.1038\/s12276-023-01070-5.","DOI":"10.1038\/s12276-023-01070-5."},{"key":"4652_CR82","doi-asserted-by":"publisher","unstructured":"Schappe MS, Stremska ME, Busey GW, Downs TK, Seegren PV, Mendu SK, et al. Efferocytosis requires periphagosomal Ca2+-signaling and TRPM7-mediated electrical activity. Nat Commun. 2022;13. https:\/\/doi.org\/10.1038\/s41467-022-30959-4.","DOI":"10.1038\/s41467-022-30959-4"},{"key":"4652_CR83","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1016\/j.molcel.2023.06.004","volume":"83","author":"J Zhang","year":"2023","unstructured":"Zhang J, Zeng W, Han Y, Lee W-R, Liou J, Jiang Y. Lysosomal LAMP proteins regulate lysosomal pH by direct inhibition of the TMEM175 channel. Mol Cell. 2023;83:2524\u2013e25397. https:\/\/doi.org\/10.1016\/j.molcel.2023.06.004.","journal-title":"Mol Cell"},{"key":"4652_CR84","doi-asserted-by":"publisher","unstructured":"Ge Y, Huang M, Yao Y. Efferocytosis and Its Role in Inflammatory Disorders. Front Cell Dev Biology. 2022;10. https:\/\/doi.org\/10.3389\/fcell.2022.839248.","DOI":"10.3389\/fcell.2022.839248"},{"key":"4652_CR85","doi-asserted-by":"publisher","first-page":"107281","DOI":"10.1016\/j.phrs.2024.107281","volume":"206","author":"K Cai","year":"2024","unstructured":"Cai K, Jiang H, Zou Y, Song C, Cao K, Chen S, et al. Programmed death of cardiomyocytes in cardiovascular disease and new therapeutic approaches. Pharmacol Res. 2024;206:107281. https:\/\/doi.org\/10.1016\/j.phrs.2024.107281.","journal-title":"Pharmacol Res"},{"key":"4652_CR86","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/cvr\/cvac113","volume":"119","author":"G Rizzo","year":"2022","unstructured":"Rizzo G, Gropper J, Piollet M, Vafadarnejad E, Rizakou A, Bandi SR, et al. Dynamics of monocyte-derived macrophage diversity in experimental myocardial infarction. Cardiovascular Res. 2022;119:772\u201385. https:\/\/doi.org\/10.1093\/cvr\/cvac113.","journal-title":"Cardiovascular Res"},{"key":"4652_CR87","doi-asserted-by":"publisher","unstructured":"Sun B, Long Y, Xu G, Chen J, Wu G, Liu B, et al. Acute hypoxia modulate macrophage phenotype accompanied with transcriptome re-programming and metabolic re-modeling. Front Immunol. 2025;16. https:\/\/doi.org\/10.3389\/fimmu.2025.1534009.","DOI":"10.3389\/fimmu.2025.1534009"},{"key":"4652_CR88","doi-asserted-by":"publisher","unstructured":"Saimoto Y, Kusakabe D, Morimoto K, Matsuoka Y, Kozakura E, Kato N, et al. Lysosomal lipid peroxidation contributes to ferroptosis induction via lysosomal membrane permeabilization. Nat Commun. 2025;16. https:\/\/doi.org\/10.1038\/s41467-025-58909-w.","DOI":"10.1038\/s41467-025-58909-w"},{"key":"4652_CR89","doi-asserted-by":"publisher","unstructured":"Singh B, Li K, Cui K, Peng Q, Cowan DB, Wang D-Z, et al. Defective efferocytosis of vascular cells in heart disease. Front Cardiovasc Med. 2022;9. https:\/\/doi.org\/10.3389\/fcvm.2022.1031293.","DOI":"10.3389\/fcvm.2022.1031293"},{"key":"4652_CR90","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1161\/circresaha.123.324023","volume":"135","author":"C-K Huang","year":"2024","unstructured":"Huang C-K, Chen Z, Zhou Z, Chen S, Chen L, Li L, et al. RNF149 Destabilizes IFNGR1 in Macrophages to Favor Postinfarction Cardiac Repair. Circul Res. 2024;135:518\u201336. https:\/\/doi.org\/10.1161\/circresaha.123.324023.","journal-title":"Circul Res"},{"key":"4652_CR91","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.cell.2024.10.047","volume":"188","author":"Y Wang","year":"2025","unstructured":"Wang Y, Hu M, Cao J, Wang F, Han JR, Wu TW, et al. ACSL4 and polyunsaturated lipids support metastatic extravasation and colonization. Cell. 2025;188:412\u2013e42927. https:\/\/doi.org\/10.1016\/j.cell.2024.10.047.","journal-title":"Cell"},{"key":"4652_CR92","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1002\/ejhf.3703","volume":"27","author":"G Fragasso","year":"2025","unstructured":"Fragasso G, Stolfo D, Anker MS, Bayes-Genis A, Chioncel O, Heymans S, et al. The Crosstalk Between Immune Activation and Metabolism in Heart Failure. A Scientific Statement of the Heart Failure Association of the ESC. Eur J Heart Fail. 2025;27:1700\u201319. https:\/\/doi.org\/10.1002\/ejhf.3703.","journal-title":"Eur J Heart Fail"},{"key":"4652_CR93","doi-asserted-by":"publisher","unstructured":"Desai N, Rana D, Patel M, Bajwa N, Prasad R, Vora LK. Nanoparticle Therapeutics in Clinical Perspective: Classification, Marketed Products, and Regulatory Landscape. Small. 2025;21. https:\/\/doi.org\/10.1002\/smll.202502315.","DOI":"10.1002\/smll.202502315"},{"key":"4652_CR94","doi-asserted-by":"publisher","unstructured":"Weng H, Zou W, Tian F, Xie H, Liu A, Liu W, et al. Inhalable cardiac targeting peptide modified nanomedicine prevents pressure overload heart failure in male mice. Nat Commun. 2024;15. https:\/\/doi.org\/10.1038\/s41467-024-50312-1.","DOI":"10.1038\/s41467-024-50312-1"},{"key":"4652_CR95","doi-asserted-by":"publisher","unstructured":"Peng C, Zhang Y, Lang X, Zhang Y. Role of mitochondrial metabolic disorder and immune infiltration in diabetic cardiomyopathy: new insights from bioinformatics analysis. J Translational Med. 2023;21. https:\/\/doi.org\/10.1186\/s12967-023-03928-8.","DOI":"10.1186\/s12967-023-03928-8"},{"key":"4652_CR96","doi-asserted-by":"publisher","unstructured":"Zhang D, Wen Q, Zhang R, Kou K, Lin M, Zhang S, et al. From Cell to Gene: Deciphering the Mechanism of Heart Failure With Single-Cell Sequencing. Adv Sci. 2024;11. https:\/\/doi.org\/10.1002\/advs.202308900.","DOI":"10.1002\/advs.202308900"},{"key":"4652_CR97","doi-asserted-by":"publisher","unstructured":"Zhao Y, Xiong W, Li C, Zhao R, Lu H, Song S, et al. Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets. Signal Transduct Target Therapy. 2023;8. https:\/\/doi.org\/10.1038\/s41392-023-01652-9.","DOI":"10.1038\/s41392-023-01652-9"},{"key":"4652_CR98","doi-asserted-by":"publisher","unstructured":"Xiao H, Zhang W, Liu J, Ma Y, Liu D, Li M, et al. Engineered Therapeutic Nanoplatforms for Ischemic Heart Disease Treatment Vis Cardiac Microenvironment Reprogramming. Adv Healthc Mater. 2026;15. https:\/\/doi.org\/10.1002\/adhm.202503560.","DOI":"10.1002\/adhm.202503560"},{"key":"4652_CR99","doi-asserted-by":"publisher","DOI":"10.1002\/anbr.202200005","author":"E Handley","year":"2022","unstructured":"Handley E, Callanan A. Modulation of Tissue Microenvironment Following Myocardial Infarction. Adv NanoBiomed Res. 2022. https:\/\/doi.org\/10.1002\/anbr.202200005. 2.","journal-title":"Adv NanoBiomed Res"},{"key":"4652_CR100","doi-asserted-by":"publisher","unstructured":"Chen R, Zhang H, Tang B, Luo Y, Yang Y, Zhong X, et al. Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets. Signal Transduct Target Therapy. 2024;9. https:\/\/doi.org\/10.1038\/s41392-024-01840-1.","DOI":"10.1038\/s41392-024-01840-1"},{"key":"4652_CR101","doi-asserted-by":"publisher","unstructured":"Hu D, Li R, Li Y, Wang M, Wang L, Wang S, et al. Inflammation-Targeted Nanomedicines Alleviate Oxidative Stress and Reprogram Macrophages Polarization for Myocardial Infarction Treatment. Adv Sci. 2024;11. https:\/\/doi.org\/10.1002\/advs.202308910.","DOI":"10.1002\/advs.202308910"},{"key":"4652_CR102","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1161\/circulationaha.123.067097","volume":"149","author":"T Liu","year":"2024","unstructured":"Liu T, Hao Y, Zhang Z, Zhou H, Peng S, Zhang D, et al. Advanced Cardiac Patches for the Treatment of Myocardial Infarction. Circulation. 2024;149:2002\u201320. https:\/\/doi.org\/10.1161\/circulationaha.123.067097.","journal-title":"Circulation"},{"key":"4652_CR103","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41418-023-01252-8","volume":"31","author":"S Gong","year":"2024","unstructured":"Gong S, Zhai M, Shi J, Yu G, Lei Z, Shi Y, et al. TREM2 macrophage promotes cardiac repair in myocardial infarction by reprogramming metabolism via SLC25A53. Cell Death Differ. 2024;31:239\u201353. https:\/\/doi.org\/10.1038\/s41418-023-01252-8.","journal-title":"Cell Death Differ"},{"key":"4652_CR104","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1161\/circresaha.124.325402","volume":"136","author":"R Ghazal","year":"2025","unstructured":"Ghazal R, Wang M, Liu D, Tschumperlin DJ, Pereira NL. Cardiac Fibrosis in the Multi-Omics Era: Implications for Heart Failure. Circul Res. 2025;136:773\u2013802. https:\/\/doi.org\/10.1161\/circresaha.124.325402.","journal-title":"Circul Res"},{"key":"4652_CR105","doi-asserted-by":"publisher","unstructured":"Tapeinos C, Gao H, Bauleth-Ramos T, Santos HA. Progress in Stimuli\u2010Responsive Biomaterials for Treating Cardiovascular and Cerebrovascular Diseases. Small. 2022;18. https:\/\/doi.org\/10.1002\/smll.202200291.","DOI":"10.1002\/smll.202200291"},{"key":"4652_CR106","doi-asserted-by":"publisher","unstructured":"Zhang Y, Jiang M, Wang T. Reactive oxygen species (ROS)-responsive biomaterials for treating myocardial ischemia-reperfusion injury. Front Bioeng Biotechnol. 2024;12. https:\/\/doi.org\/10.3389\/fbioe.2024.1469393.","DOI":"10.3389\/fbioe.2024.1469393"},{"key":"4652_CR107","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/gels8020097","volume":"8","author":"RK Sindhu","year":"2022","unstructured":"Sindhu RK, Gupta R, Wadhera G, Kumar P. Modern Herbal Nanogels: Formulation, Delivery Methods, and Applications. Gels. 2022;8:97. https:\/\/doi.org\/10.3390\/gels8020097.","journal-title":"Gels"},{"key":"4652_CR108","doi-asserted-by":"publisher","unstructured":"Li X, Ou W, Xie M, Yang J, Li Q, Li T. Nanomedicine-Based Therapeutics for Myocardial Ischemic\/Reperfusion Injury. Adv Healthc Mater. 2023;12. https:\/\/doi.org\/10.1002\/adhm.202300161.","DOI":"10.1002\/adhm.202300161"},{"key":"4652_CR109","doi-asserted-by":"publisher","unstructured":"Zhu K, Wang K, Zhang R, Zhu Z, Wang W, Yang B, et al. Iron chelators loaded on myocardiocyte mitochondria-targeted nanozyme system for treating myocardial ischemia-reperfusion injury in mouse models. J Nanobiotechnol. 2025;23. https:\/\/doi.org\/10.1186\/s12951-025-03197-1.","DOI":"10.1186\/s12951-025-03197-1"},{"key":"4652_CR110","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41569-021-00629-x","volume":"19","author":"W Chen","year":"2021","unstructured":"Chen W, Schilperoort M, Cao Y, Shi J, Tabas I, Tao W. Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis. Nat Reviews Cardiol. 2021;19:228\u201349. https:\/\/doi.org\/10.1038\/s41569-021-00629-x.","journal-title":"Nat Reviews Cardiol"},{"key":"4652_CR111","doi-asserted-by":"publisher","unstructured":"Zelepukin IV, Shevchenko KG, Deyev SM. Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery. Nat Commun. 2024;15. https:\/\/doi.org\/10.1038\/s41467-024-48838-5.","DOI":"10.1038\/s41467-024-48838-5"},{"key":"4652_CR112","doi-asserted-by":"publisher","unstructured":"Gao J, Pang Z, Wang Q, Tan Y, Li Q, Tan H, et al. Biomimetic Nano-Degrader Based CD47\u2010SIRP\u03b1 Immune Checkpoint Inhibition Promotes Macrophage Efferocytosis for Cardiac Repair. Adv Sci. 2024;11. https:\/\/doi.org\/10.1002\/advs.202306388.","DOI":"10.1002\/advs.202306388"},{"key":"4652_CR113","doi-asserted-by":"publisher","first-page":"10353","DOI":"10.2147\/ijn.s533628","volume":"20","author":"Q Pan","year":"2025","unstructured":"Pan Q, Chen G, Zhuang X, Li F, Yang Y. Cardiac Homing Peptide-Functionalized Polymeric Nanoparticles Suppressing SHP1 Alleviate Acute Myocardial Infarction Injury by Promoting Efferocytosis and Inhibiting Inflammation. Int J Nanomed. 2025;20:10353\u201367. https:\/\/doi.org\/10.2147\/ijn.s533628.","journal-title":"Int J Nanomed"},{"key":"4652_CR114","doi-asserted-by":"publisher","unstructured":"Zhang B, Zou Y, Yuan Z, Jiang K, Zhang Z, Chen S, et al. Efferocytosis: the resolution of inflammation in cardiovascular and cerebrovascular disease. Front Immunol. 2024;15. https:\/\/doi.org\/10.3389\/fimmu.2024.1485222.","DOI":"10.3389\/fimmu.2024.1485222"},{"key":"4652_CR115","doi-asserted-by":"publisher","unstructured":"Tan H, Li W, Pang Z, Weng X, Gao J, Chen J, et al. Genetically Engineered Macrophages Co-Loaded with CD47 Inhibitors Synergistically Reconstruct Efferocytosis and Improve Cardiac Remodeling Post Myocardial Ischemia Reperfusion Injury. Adv Healthc Mater. 2024;13. https:\/\/doi.org\/10.1002\/adhm.202303267.","DOI":"10.1002\/adhm.202303267"},{"key":"4652_CR116","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1021\/acsptsci.4c00292","volume":"7","author":"Y Patel","year":"2024","unstructured":"Patel Y, Manturthi S, Tiwari S, Gahunia E, Courtemanche A, Gandelman M, et al. Development of Pro-resolving and Pro-efferocytic Nanoparticles for Atherosclerosis Therapy. ACS Pharmacol Translational Sci. 2024;7:3086\u201395. https:\/\/doi.org\/10.1021\/acsptsci.4c00292.","journal-title":"ACS Pharmacol Translational Sci"},{"key":"4652_CR117","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1038\/s42255-023-00921-9","volume":"5","author":"D Ngai","year":"2023","unstructured":"Ngai D, Schilperoort M, Tabas I. Efferocytosis-induced lactate enables the proliferation of pro-resolving macrophages to mediate tissue repair. Nat Metabolism. 2023;5:2206\u201319. https:\/\/doi.org\/10.1038\/s42255-023-00921-9.","journal-title":"Nat Metabolism"},{"key":"4652_CR118","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1038\/s42255-024-01115-7","volume":"6","author":"SR Sukka","year":"2024","unstructured":"Sukka SR, Ampomah PB, Darville LNF, Ngai D, Wang X, Kuriakose G, et al. Efferocytosis drives a tryptophan metabolism pathway in macrophages to promote tissue resolution. Nat Metabolism. 2024;6:1736\u201355. https:\/\/doi.org\/10.1038\/s42255-024-01115-7.","journal-title":"Nat Metabolism"},{"key":"4652_CR119","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1002\/ehf2.14947","volume":"12","author":"Z Fang","year":"2024","unstructured":"Fang Z, Raza U, Song J, Lu J, Yao S, Liu X, et al. Systemic Aging Fuels Heart Failure: Molecular Mechanisms and Therapeutic Avenues. ESC Heart Fail. 2024;12:1059\u201380. https:\/\/doi.org\/10.1002\/ehf2.14947.","journal-title":"ESC Heart Fail"},{"key":"4652_CR120","doi-asserted-by":"publisher","first-page":"103424","DOI":"10.1016\/j.redox.2024.103424","volume":"78","author":"H Zhang","year":"2024","unstructured":"Zhang H, Gao Y, Zhang M, Yuan Z, Chen Y, Wang A, et al. Schaftoside improves HFpEF through regulation the autophagy-lysosome pathway by allosterically targeting CaMKII-\u03b4. Redox Biol. 2024;78:103424. https:\/\/doi.org\/10.1016\/j.redox.2024.103424.","journal-title":"Redox Biol"},{"key":"4652_CR121","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s44161-023-00232-y","volume":"2","author":"BR Smith","year":"2023","unstructured":"Smith BR, Edelman ER. Nanomedicines for cardiovascular disease. Nat Cardiovasc Res. 2023;2:351\u201367. https:\/\/doi.org\/10.1038\/s44161-023-00232-y.","journal-title":"Nat Cardiovasc Res"},{"key":"4652_CR122","doi-asserted-by":"publisher","first-page":"123271","DOI":"10.1016\/j.biomaterials.2025.123271","volume":"320","author":"Y Mao","year":"2025","unstructured":"Mao Y, Shi X, Sun P, Spanos M, Zhu L, Chen H, et al. Nanomedicines for cardiovascular diseases: Lessons learned and pathways forward. Biomaterials. 2025;320:123271. https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123271.","journal-title":"Biomaterials"},{"key":"4652_CR123","doi-asserted-by":"publisher","unstructured":"Li Y, Li P, Wang W, Zhang Y, Li S, Li D, et al. Nanoparticle-based drug delivery systems targeting inflammatory immune mechanisms in acute myocardial infarction: current advances and perspectives. Front Cardiovasc Med. 2025;12. https:\/\/doi.org\/10.3389\/fcvm.2025.1657300.","DOI":"10.3389\/fcvm.2025.1657300"},{"key":"4652_CR124","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.actbio.2023.09.011","volume":"171","author":"J Guo","year":"2023","unstructured":"Guo J, Wang H, Li Y, Zhu S, Hu H, Gu Z. Nanotechnology in coronary heart disease. Acta Biomater. 2023;171:37\u201367. https:\/\/doi.org\/10.1016\/j.actbio.2023.09.011.","journal-title":"Acta Biomater"},{"key":"4652_CR125","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3390\/pharmaceutics15041053","volume":"15","author":"A Vogelaar","year":"2023","unstructured":"Vogelaar A, Marcotte S, Cheng J, Oluoch B, Zaro J. Use of Microfluidics to Prepare Lipid-Based Nanocarriers. Pharmaceutics. 2023;15:1053. https:\/\/doi.org\/10.3390\/pharmaceutics15041053.","journal-title":"Pharmaceutics"},{"key":"4652_CR126","doi-asserted-by":"publisher","unstructured":"Piunti C, Cimetta E. Microfluidic approaches for producing lipid-based nanoparticles for drug delivery applications. Biophys Reviews. 2023;4. https:\/\/doi.org\/10.1063\/5.0150345.","DOI":"10.1063\/5.0150345"},{"key":"4652_CR127","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.tcb.2025.01.005","volume":"35","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Fujimaki M, Rubinsztein DC. Autophagy-dependent versus autophagy-independent ferroptosis. Trends Cell Biol. 2025;35:745\u201360. https:\/\/doi.org\/10.1016\/j.tcb.2025.01.005.","journal-title":"Trends Cell Biol"},{"key":"4652_CR128","doi-asserted-by":"publisher","unstructured":"Halade GV, B\u00e4ck M, Kain V. Inflammation-resolution signalling in cardiac repair, remodelling, and heart failure. Eur Heart J Open. 2025;5. https:\/\/doi.org\/10.1093\/ehjopen\/oeaf157.","DOI":"10.1093\/ehjopen\/oeaf157"},{"key":"4652_CR129","doi-asserted-by":"publisher","unstructured":"Nakayama Y, Fujiu K, Oshima T, Matsuda J, Sugita J, Matsubara TJ, et al. Heart failure promotes multimorbidity through innate immune memory. Sci Immunol. 2024;9. https:\/\/doi.org\/10.1126\/sciimmunol.ade3814.","DOI":"10.1126\/sciimmunol.ade3814"},{"key":"4652_CR130","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1002\/ehf2.15168","volume":"12","author":"AP R\u00e1duly","year":"2024","unstructured":"R\u00e1duly AP, Nagy L, B\u00f3di B, Papp Z, Borb\u00e9ly A. Biomarkers in Heart Failure: Traditional and Emerging Indicators for Prognosis. ESC Heart Fail. 2024;12:1535\u20138. https:\/\/doi.org\/10.1002\/ehf2.15168.","journal-title":"ESC Heart Fail"},{"key":"4652_CR131","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.jacc.2023.01.049","volume":"81","author":"BA Borlaug","year":"2023","unstructured":"Borlaug BA, Sharma K, Shah SJ, Ho JE. Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol. 2023;81:1810\u201334. https:\/\/doi.org\/10.1016\/j.jacc.2023.01.049.","journal-title":"J Am Coll Cardiol"},{"key":"4652_CR132","doi-asserted-by":"publisher","unstructured":"Kosyakovsky LB, Liu EE, Wang JK, Myers L, Parekh JK, Knauss H, et al. Uncovering Unrecognized Heart Failure With Preserved Ejection Fraction Among Individuals With Obesity and Dyspnea. Circulation: Heart Fail. 2024;17. https:\/\/doi.org\/10.1161\/circheartfailure.123.011366.","DOI":"10.1161\/circheartfailure.123.011366"},{"key":"4652_CR133","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/ejhf.3268","volume":"26","author":"A Esquivel Gaytan","year":"2024","unstructured":"Esquivel Gaytan A, Bomer N, van der Grote Beverborg N. 404-Error Disease Not Found: Unleashing the Translational Potential of -Omics Approaches Beyond Traditional Disease Classification in Heart Failure Research. Eur J Heart Fail. 2024;26:1313\u201323. https:\/\/doi.org\/10.1002\/ejhf.3268.","journal-title":"Eur J Heart Fail"},{"key":"4652_CR134","doi-asserted-by":"publisher","unstructured":"Wu J, Zhao M, Li T, Sun J, Chen Q, Yin C, et al. HFIP: an integrated multi-omics data and knowledge platform for the precision medicine of heart failure. Database. 2021;2021. https:\/\/doi.org\/10.1093\/database\/baab076.","DOI":"10.1093\/database\/baab076"},{"key":"4652_CR135","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1161\/atvbaha.122.318731","volume":"43","author":"R-S Wang","year":"2023","unstructured":"Wang R-S, Maron BA, Loscalzo J, Arteriosclerosis. Thromb Vascular Biology. 2023;43:493\u2013503. https:\/\/doi.org\/10.1161\/atvbaha.122.318731.","journal-title":"Thromb Vascular Biology"},{"key":"4652_CR136","doi-asserted-by":"publisher","first-page":"136","DOI":"10.54912\/jci.2024.0009","volume":"3","author":"WB Jang","year":"2024","unstructured":"Jang WB, Kwon S-M. Bioengineering the Heart: Harnessing Biomaterials for Innovative Cardiovascular Interventions. J Cardiovasc Intervention. 2024;3:136. https:\/\/doi.org\/10.54912\/jci.2024.0009.","journal-title":"J Cardiovasc Intervention"},{"key":"4652_CR137","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1161\/circulationaha.123.065390","volume":"149","author":"M Sun","year":"2024","unstructured":"Sun M, Mao S, Wu C, Zhao X, Guo C, Hu J, et al. Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction. Circulation. 2024;149:1516\u201333. https:\/\/doi.org\/10.1161\/circulationaha.123.065390.","journal-title":"Circulation"},{"key":"4652_CR138","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-024-08463-0","volume":"639","author":"A-F Jebran","year":"2025","unstructured":"Jebran A-F, Seidler T, Tiburcy M, Daskalaki M, Kutschka I, Fujita B, et al. Engineered heart muscle allografts for heart repair in primates and humans. Nature. 2025;639:503\u201311. https:\/\/doi.org\/10.1038\/s41586-024-08463-0.","journal-title":"Nature"},{"key":"4652_CR139","doi-asserted-by":"publisher","unstructured":"Wan J, Zhang Z, Wu C, Tian S, Zang Y, Jin G, et al. Astragaloside IV derivative HHQ16 ameliorates infarction-induced hypertrophy and heart failure through degradation of lncRNA4012\/9456. Signal Transduct Target Therapy. 2023;8. https:\/\/doi.org\/10.1038\/s41392-023-01660-9.","DOI":"10.1038\/s41392-023-01660-9"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04652-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04652-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04652-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T02:24:30Z","timestamp":1786587870000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04652-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":139,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4652"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04652-3","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"2 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"747"}}